Heart Failure: Older patients & COVID-related heart damage | Hydroxychloroquine & azithromycin | Empagliflozin

Chemists have uncovered a new technique that could make it possible to heal a patient’s damaged heart tissue after a myocardial infarction (MI).

COVID-19 enters a person’s heart cells by attacking certain proteins—and when more of those proteins are present, the virus has more chances to cause damage.

The meta-analysis included data from more than 950,000 patients.

“We think we’ve found a way to quiet that inflammatory environment, giving stem cells a chance to survive and do the healing work we know they can do,” one researcher said. 

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

Myocarditis continues to make headlines in the world of college athletics. 

Cardiologists may way want to pay close attention to a new study published in the American Journal of Cardiology.

Trabeculae, detailed networks of muscle fibers on the heart, were first sketched by Leonardo da Vinci 500 years ago. He wondered what they were and what, exactly, they did.

The proposed changes, announced August 12, are focused on easing a variety of requirements.